✓ Independent editorial reviews of U.S. telehealth providers · Updated June 1, 2026 · Educational only — not medical advice
Drug Reference · Updated 2026-06-01

Compounded Semaglutide

Patient-specific or office-stock semaglutide preparation dispensed by a 503A licensed compounding pharmacy or 503B FDA-registered outsourcing facility. Not FDA-approved.

By 503A or 503B pharmacyUpdated 2026-06-01
SS
Editorial team
Dr. Sam Saberian · Lead Medical Researcher
Medical review by Alen A. Schwartz, MD · Edited by Julliana Edwards · Last updated 2026-06-01

Compounded Semaglutide overview

Patient-specific or office-stock semaglutide preparation dispensed by a 503A licensed compounding pharmacy or 503B FDA-registered outsourcing facility. Not FDA-approved.

Compounded Semaglutide at a glance

Manufacturer
503A or 503B pharmacy
FDA status
Not FDA-approved (compounded)

Related pages